<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Vincenzi M</submitter><funding>AIRC</funding><funding>Italian Association for Cancer Research</funding><pagination>10616</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11476629</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>25(19)</volume><pubmed_abstract>The Sam (Sterile alpha motif) domain of the lipid phosphatase Ship2 (Ship2-Sam) is engaged by the Sam domain of the receptor tyrosine kinase EphA2 (EphA2-Sam) and, this interaction is principally linked to procancer effects. Peptides able to hinder the formation of the EphA2-Sam/Ship2-Sam complex could possess therapeutic potential. Herein, by employing the FoldX software suite, we set up an in silico approach to improve the peptide targeting of the so-called Mid Loop interface of Ship2-Sam, representing the EphA2-Sam binding site. Starting from a formerly identified peptide antagonist of the EphA2-Sam/Ship2-Sam association, first, the most stabilizing mutations that could be inserted in each peptide position were predicted. Then, they were combined, producing a list of potentially enhance</pubmed_abstract><journal>International journal of molecular sciences</journal><pubmed_title>Exploring a Potential Optimization Route for Peptide Ligands of the Sam Domain from the Lipid Phosphatase Ship2.</pubmed_title><pmcid>PMC11476629</pmcid><funding_grant_id>26121</funding_grant_id><funding_grant_id>IG26121</funding_grant_id><pubmed_authors>Mercurio FA</pubmed_authors><pubmed_authors>Vincenzi M</pubmed_authors><pubmed_authors>Marasco D</pubmed_authors><pubmed_authors>Palumbo R</pubmed_authors><pubmed_authors>Leone M</pubmed_authors><pubmed_authors>La Manna S</pubmed_authors><pubmed_authors>Pirone L</pubmed_authors><pubmed_authors>Pedone EM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Exploring a Potential Optimization Route for Peptide Ligands of the Sam Domain from the Lipid Phosphatase Ship2.</name><description>The Sam (Sterile alpha motif) domain of the lipid phosphatase Ship2 (Ship2-Sam) is engaged by the Sam domain of the receptor tyrosine kinase EphA2 (EphA2-Sam) and, this interaction is principally linked to procancer effects. Peptides able to hinder the formation of the EphA2-Sam/Ship2-Sam complex could possess therapeutic potential. Herein, by employing the FoldX software suite, we set up an in silico approach to improve the peptide targeting of the so-called Mid Loop interface of Ship2-Sam, representing the EphA2-Sam binding site. Starting from a formerly identified peptide antagonist of the EphA2-Sam/Ship2-Sam association, first, the most stabilizing mutations that could be inserted in each peptide position were predicted. Then, they were combined, producing a list of potentially enhance</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Oct</publication><modification>2026-06-30T03:17:01.388Z</modification><creation>2025-04-04T11:05:23.227Z</creation></dates><accession>S-EPMC11476629</accession><cross_references><pubmed>39408946</pubmed><doi>10.3390/ijms251910616</doi></cross_references></HashMap>